Q4 2024 Management View CEO Michel Brousset highlighted that 2024 was a transformative year for Waldencast, with strong performance from its brands, Milk Makeup and Obagi Medical, both significantly ...

By Karen Roman Waldencast plc (Nasdaq: WALD) said fourth quarter net revenue grew 30.8% to $72.1 million. Adjusted EBITDA ...

Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt mat ...

Waldencast has released its fourth-quarter and full-year 2024 earnings, reporting double-digit net revenue growth and an updated US$205m credit facility.

Obagi Medical revenue came in at $34.6M in Q2, up 31% from a year ago. Milk Makeup revenue was up 20% at $28.7M. Net loss for ...